A Scientific leader, innovator & expert in the Respiratory field. Driver of pre-competitive patient-focused international partnerships and collaborations.
Pennsylvania, USA
Joined September 2015
- Tweets917
- Following153
- Followers320
- Likes2.8K
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Some GAAPP email accounts were compromised. We're investigating with cybersecurity experts and upgrading our systems. GAAPP will NEVER ask for money or private info via email. If you get a suspicious message, disregard it and verify with us directly. Thank you.
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
#AskMeAnythingEczema: How can families manage eczema in low-resource settings? Dr. Evelyne Ng'ang'a explains. Stay tuned for more Q&A videos about atopic eczema on our socials today.
Learn more: gaapp.org/eczemaday
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
#AskMeAnythingEczema: This World Atopic Eczema Day, get ready to chat with Dr. Anahi Yáñez, from Argentina. Drop your Q below! gaapp.org/eczemaday
.
*This forum does not replace a one-on-one consultation with your own healthcare professional.
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
First day and already I know this will be my favourite session of the congress
Thank you to all of our patients and tk @EuropeanLung - you’ve changed the clinical and scientific landscape in bronchiectasis and many other respiratory diseases ❤️
💙 Thank you to everyone who made #ELFPatientOrgDay2026 such a success!
Speakers, chairs and attendees from ERS and across our network shared experiences and ideas, highlighting the power of patient-professional collaboration.
#ERSCongress2026 #PatientVoice @EuroRespSoc 🫁💙
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Exacerbations are critical in #Bronchiectasis, and each prior exacerbation counts on future risk, especially the severe ones.
Thrilled to present our last #EMBARC paper at the #WBConf26 journal session, published today at the #AJRCCM @ATSBlueEditor
👉doi.org/10.1093/ajrccm/aamag…
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Allergic fungal rhinosinusitis (#AFRS) represents 5–15% of chronic rhinosinusitis cases, but a lack of specific clinical guidelines often leads to misdiagnosis, delayed treatment, and risk of bone erosion. Help your patients stop guessing. 👉 gaapp.org/AFRS
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
GAAPP Member Organizations: Registrations for the GAAPP Summit and Annual General Meeting 2026 close TODAY!
📅 03 & 04 September 2026
📍 Barcelona, Spain
✈️ Accommodation & Travel for one representative per member org
🔗 gaapp.org/gaapp-summit-2026
#GAAPPSummit2026
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Are you a patient or caregiver affected by bronchiectasis?
Come join the Association & Patient Programme at #WBConf26
Get helpful knowledge and insights - through Interactive sessions on self-care, real-life challenges, and emotional wellbeing.
🔗 bit.ly/4tibfW1
ALT Are you a patient or caregiver affected by bronchiectasis? Come join the Association & Patient Programme at #WBConf26 Get helpful knowledge and insights - through Interactive sessions on self-care, real-life challenges, and emotional wellbeing. 🔗 https://bit.ly/4tibfW1
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Tomorrow, on World #EoEDay, we're hosting a multidisciplinary webinar dedicated to advancing the global understanding of EoE. 🕓 13:00 Central Europe Time
📍 REGISTER: eoeday.org/webinar
.
#FoodShouldNotHurt
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Meet the new #AsthmaCareMap: A tool for concrete examples and evidence of asthma-based research. It compiles 1,937 research insights from 153 peer-reviewed publications, public health reports, and clinical guidelines into a single, organized resource.
🔗 asthmacaremap.com
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
#ICAN2026: Call for abstracts for early career researchers (5 September, Barcelona). Topics: Immune mechanisms and treatment response to AI, imaging, and novel therapies. Selected abstracts receive travel, accommodation support. Deadline extended: 22 May 🔗ican.gaapp.org
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
#ICAN2026: Call for abstracts for early career researchers (5 September, Barcelona). Topics: Immune mechanisms and treatment response to AI, imaging, and novel therapies. Selected abstracts receive travel support + accommodation. Deadline: 15 April, 2026 🔗ican.gaapp.org
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Both 10mg and 25mg brensocatib has been approved in the US for treatment of bronchiectasis.
In the absence of official guidance, Chuck Daley and i comment on optimal dosing, concluding that 25mg should be the preferred dose for patients
@ATSBlueEditor
academic.oup.com/ajrccm/adva…
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Call for Abstracts for Early Career Researchers: share your work at ICAN 2026 (5 September, Barcelona). Join a collaborative community advancing respiratory research — from immune mechanisms and treatment response to AI, imaging, and novel therapies. Connect with peers and global experts across academia, industry, NIH, ERS, and more. Only 50 abstracts will be selected.
✈️ Selected abstracts will receive travel support + accommodation
📅 Deadline: 15 April, 2026
🔗 ican.gaapp.org
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Check our new interactive learning module on bronchiectasis - talking about the new ERS guidelines and much more with Sanjay Chotirmall and Natalie Lorent ❤️
New Interactive Education: Unmasking bronchiectasis – From guidelines to the bedside: expert case reflections
Join the experts as they discuss the critical need for high-quality, case-based learning to help clinicians improve practice in bronchiectasis: channel.ersnet.org/media-121…
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
What about the other pathogens i hear you say?
@alferes_de and @lifearc1 have you covered
Rapid rRNA detection of H. influenzae, S. aureus, S. pneumoniae and M. catarrhalis in bronchiectasis sputum. Better than culture- the future of micro is molecular!
publications.ersnet.org/cont…
New paper! Collaboration between @EMBARCnetwork and @lifearc1 shows a molecular test can sensitively and accurately detect and quantify Pseudomonas infection in bronchiectasis.
The BQA was better than culture
@alferes_de @beccahull_ @MereteLong @OSibila
publications.ersnet.org/cont…
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Our latest paper just out in @LancetRespirMed
10 unanswered questions about DPP1 inhibition in bronchiectasis
We outline key future clinical and research questions after the approval of the first new therapy for people with bronchiectasis.
Congratulations Jiahui, Chloe and @MereteLong
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
In celebration of International Women’s Day, join us for the next #GAAPPAcademy webinar! 9 global experts share their journey with leadership and community impact as they discuss “The Role of Women in Patient Advocacy”.
🗓 9 March 2026 🕒 15:00 CET 🔗 Register: us06web.zoom.us/webinar/regi…
R Tal-Singer Lung Health Researcher & Advocate 🫁 retweeted
Brensocatib did not meet primary or secondary endpoints in the phase 2 BIRCH study in chronic rhinosinusitis without nasal polyps.
Difficult/complex disease and interested to see the full data. Safety reassuring as with previous studies in bronchiectasis
investor.insmed.com/2025-12-…
